Merdica Private Limited

Sitagliptin 50 mg & Metformin Hydrochloride 1000 mg Tablets.
Brand Name: SITAPLIZIN MET 50mg/1000mg

vildagliptin 50 mg + metformin 1000 mg is a combination of two antidiabetic medicines: Metformin and Vildagliptin. Metformin is an anti-diabetic medication (biguanide). It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.

Dapagliflozin 10 mg and Sitagliptin Phosphate 100 mg Tablets. Brand Name is Sitaplizin D 10/100. Packing: 10 x 10

vildagliptin 50 mg + metformin 500 mg is a combination of two antidiabetic medicines: Metformin and Vildagliptin. Metformin is an anti-diabetic medication (biguanide). It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.

Sitagliptin Tablet is a prescription medicine used to treat type 2 diabetes mellitus by helping to control blood sugar levels. It is not used for type 1 diabetes or diabetic ketoacidosis.

 VOGDEK GM 0.3/3 (Voglibose 0.3 mg + Glimepiride 3 mg + Metformin 500 mg SR):

Product Information

- Brand Name: VOGDEK GM 0.3/3
- Active Ingredients:
    - Voglibose 0.3 mg
    - Glimepiride 3 mg
    - Metformin 500 mg (Sustained Release)
- Form: Tablets

Therapeutic Class

- Antidiabetic agent (combination)

Indications

- Treatment of type 2 diabetes mellitus
- Improves glycemic control
- Reduces risk of complications associated with diabetes

Dosage and Administration

- Adult dose: 1 tablet once daily, with breakfast
- Adjust dose as directed by physician

Mechanism of Action

- Voglibose:
    - Inhibits intestinal alpha-glucosidases
    - Delays carbohydrate absorption
- Glimepiride:
    - Stimulates insulin release from pancreas
    - Increases insulin sensitivity
- Metformin:
    - Decreases glucose production in liver
    - Enhances insulin sensitivity

Benefits

- Effective glycemic control
- Reduced postprandial glucose spikes
- Weight-neutral or weight-loss potential
- Convenient once-daily dosing

Glimpazin-10 (Empagliflozin 10 mg Tablets):

Product Information

- Brand Name: Glimpazin-10
- Active Ingredient: Empagliflozin
- Strength: 10 mg
- Form: Tablets

Therapeutic Class

- Antidiabetic agent
- SGLT2 inhibitor

Indications

- Treatment of type 2 diabetes mellitus
- Improves glycemic control
- Reduces risk of cardiovascular events
- Adjunct to diet and exercise

Dosage and Administration

- Adult dose: 10 mg once daily, in the morning
- Take with or without food

Mechanism of Action

- Inhibits sodium-glucose cotransporter 2 (SGLT2)
- Reduces glucose reabsorption in kidneys
- Increases glucose excretion in urine

Benefits

- Effective glycemic control
- Reduced risk of cardiovascular events
- Convenient once-daily dosing
- Weight loss potential
- Improved blood pressure control

Side Effects


- Common:
    - Urinary tract infections
    - Increased urination
    - Thirst
    - Headache
    - Hypoglycemia (low blood sugar)
- Less common:
    - Allergic reactions
    - Increased risk of genital mycotic infections
    - Increased risk of acute kidney injury

Contraindications

- Hypersensitivity to empagliflozin
- Severe kidney impairment (eGFR <30 mL/min/1.73 m²)
- End-stage renal disease (ESRD)
- Dialysis
- Pregnancy and lactation (caution advised)

Precautions

- Monitor blood sugar, kidney function, and liver enzymes regularly
- Inform doctor about concomitant medications
- Caution in patients with:
    - Renal or hepatic impairment
    - History of pancreatitis
    - History of hypersensitivity reactions

Glimpazin-25 (Empagliflozin 25 mg Tablets):

Product Information


- Brand Name: Glimpazin-25
- Active Ingredient: Empagliflozin
- Strength: 25 mg
- Form: Tablets

Therapeutic Class

- Antidiabetic agent
- SGLT2 inhibitor

Indications

- Treatment of type 2 diabetes mellitus
- Improves glycemic control
- Reduces risk of cardiovascular events
- Adjunct to diet and exercise

Mechanism of Action

- Inhibits sodium-glucose cotransporter 2 (SGLT2)
- Reduces glucose reabsorption in kidneys
- Increases glucose excretion in urine

Benefits

- Effective glycemic control
- Reduced risk of cardiovascular events
- Convenient once-daily dosing
- Weight loss potential
- Improved blood pressure control

Side Effects

- Common:
    - Urinary tract infections
    - Increased urination
    - Thirst
    - Headache
    - Hypoglycemia (low blood sugar)
- Less common:
    - Allergic reactions
    - Increased risk of genital mycotic infections
    - Increased risk of acute kidney injury

Contraindications

- Hypersensitivity to empagliflozin
- Severe kidney impairment (eGFR <30 mL/min/1.73 m²)
- End-stage renal disease (ESRD)
- Dialysis
- Pregnancy and lactation (caution advised)

Precautions

- Monitor blood sugar, kidney function, and liver enzymes regularly
- Inform doctor about concomitant medications
- Caution in patients with:
    - Renal or hepatic impairment
    - History of pancreatitis
    - History of hypersensitivity reactions

Voglibose 0.2 mg + Glimepiride 2 mg + Metformin 500 mg Sustained Release Tablets. Brand name is VOGDEK GM 0.2/2

Sitaplizin Met 50/500 is a combination oral antidiabetic medication used to manage type 2 diabetes mellitus.

DAPAEDGE 5, containing Dapagliflozin 5 mg, is a medication used in the management of type 2 diabetes mellitus. It belongs to a class of drugs known as SGLT-2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream through urine. This helps in controlling high blood sugar levels, which is crucial in reducing the risk of diabetes-related complications and may also aid in preventing heart disease. It's important to note that this medication should be used as part of a comprehensive diabetes care plan, which includes diet and exercise. As with any medication, it is essential to follow the healthcare provider's instructions regarding dosage and use.

TENEQUICK M 1000, composed of Teneligliptin 20 mg and Metformin Hcl (SR) 1000 mg, is a medication used to improve glycemic control in adults with type 2 diabetes mellitus. It is particularly beneficial when treatment with both Teneligliptin and Metformin is appropriate. Teneligliptin works by increasing insulin release and decreasing blood sugar-raising hormones, while Metformin decreases glucose production in the liver and increases the body's sensitivity to insulin. This combination helps in better management of both fasting and postmeal sugar levels. It is advised to be taken as directed by a physician and should not be crushed or chewed before swallowing.

TENEQUICK M 500, composed of Teneligliptin 20 mg and Metformin Hcl (SR) 500 mg, is a medication used to improve glycemic control in adults with type 2 diabetes mellitus. It is particularly beneficial when treatment with both Teneligliptin and Metformin is appropriate. Teneligliptin works by increasing insulin release and decreasing blood sugar-raising hormones, while Metformin decreases glucose production in the liver and increases the body's sensitivity to insulin. This combination helps in better management of both fasting and postmeal sugar levels. It is advised to be taken as directed by a physician and should not be crushed or chewed before swallowing.

Gliquick 30 MR, by Merdica Pvt. Ltd., is a controlled-release tablet designed to manage blood sugar levels in type 2 diabetes. Each tablet contains 30 mg of Gliclazide, which helps to increase insulin production and decrease blood sugar. With consistent use, it aids in maintaining stable glucose levels, reducing the risk of diabetes-related complications. Gliquick 30 MR is a step towards a healthier, more balanced life.

Dapagliflozin 10 mg & Metformin 1000 mg (Extended Release). Brand name is DAPAEDGE M-10/1000. Packing is 10x10 Tablets.

Gliclazide Modified Release Tablet 60 mg. Brand name is Gliquick 60 MR. Packing is 10x10 Tablets. MRP. is Rs. 90/strip.  

GLIMPDEK M2 
Composition:- Glimepiride 2 mg- Metformin 500 mg (Prolonged Release), Therapeutic Class:- Antidiabetic agent (combination)Indications:- Treatment of type 2 diabetes mellitus- Improves glycemic control- Reduces risk of complications associated with diabetesDosage:- Typically, 1 tablet once daily, with breakfast- Adjust dose as directed by your doctor

Linagliptin 5 mg + Dapagliflozin 10 mg. Brand name: LINAPLIZIN D-5/10.
Packing: 10*10 Tablets.

GLIMPDEK M 0.5 (Metformin 500 mg PR + Glimepiride 0.5 mg):

Product Information

- Brand Name: GLIMPDEK M 0.5
- Active Ingredients:
    - Metformin 500 mg (Prolonged Release)
    - Glimepiride 0.5 mg
- Form: Tablets

Therapeutic Class

- Antidiabetic agent (combination)

Indications

- Treatment of type 2 diabetes mellitus
- Improves glycemic control
- Reduces risk of complications associated with diabetes

Dosage and Administration

- Adult dose: 1 tablet once daily, with breakfast
- Adjust dose as directed by physician

Mechanism of Action

- Metformin:
    - Decreases glucose production in liver
    - Enhances insulin sensitivity
- Glimepiride:
    - Stimulates insulin release from pancreas
    - Increases insulin sensitivity

Benefits

- Effective glycemic control
- Reduced risk of cardiovascular events
- Weight-neutral or weight-loss potential
- Convenient once-daily dosing

Dapagliflozin is used alone or in combination in adults for the treatment of type II diabetes.
Composition: Dapagliflozin Tablets 10 mg. Brand name is "DAPAEDGE 10"

Vildagliptin is used to control blood sugar levels in patients with type 2 diabetes mellitus.
Composition: Vildagliptin 50 mg Tablets. Brand name is "VIDITALIN 50"

Sitagliptin 100 mg + Dapagliflozin 10 mg + Metformin 1000 mg. Brand name is SITAPLIZIN TRIO FORTE- 10/100/1000

Dapagliflozin 10 mg + Metformin (ER) 500 mg. Brand name is DAPAEDGE M 10/500. Packing is 10 x 10 Tablets 

Metformin Hydrochloride Sustained Release Tablets IP 1000 mg.

Brand name is  "MATFORK 100 SR".

It is a medicine used together with diet to lower high blood sugar levels in patients with type 2 diabetes.

Metformin Sustained Release Tablets IP 500 mg. Brand name is  "MATFORK 500 SR".

It is a medicine used together with diet to lower high blood sugar levels in patients with type 2 diabetes.

GLIMPDEK M2 FORTE (Glimepiride 2 mg and Metformin 1000 mg):

Product Information

- Brand Name: GLIMPDEK M2 FORTE
- Active Ingredients:
    - Glimepiride 2 mg
    - Metformin 1000 mg
- Form: Tablets

Therapeutic Class

- Antidiabetic agent (combination)

Indications

- Treatment of type 2 diabetes mellitus
- Improves glycemic control
- Reduces risk of complications associated with diabetes

Dosage and Administration

- Adult dose: 1 tablet once or twice daily, with breakfast and/or dinner
- Adjust dose as directed by physician

Mechanism of Action

- Glimepiride:
    - Stimulates insulin release from pancreas
    - Increases insulin sensitivity
- Metformin:
    - Decreases glucose production in liver
    - Enhances insulin sensitivity

Benefits

- Effective glycemic control
- Reduced risk of cardiovascular events
- Weight-neutral or weight-loss potential
- Convenient once/twice-daily dosing

VOGDEK 0.2 MD (Voglibose IP 0.2 mg [Mouth dissolving]):

Product Information

- Brand Name: VOGDEK 0.2 MD
- Active Ingredient: Voglibose IP
- Strength: 0.2 mg
- Form: Tablets

Therapeutic Class

- Alpha-glucosidase inhibitor

Indications

- Treatment of type 2 diabetes mellitus
- Improves glycemic control
- Reduces postprandial glucose spikes
- Adjunct to diet and exercise

Dosage and Administration

- Adult dose: 0.2 mg three times a day, immediately before meals
- Adjust dose as directed by physician

Mechanism of Action

- Inhibits intestinal alpha-glucosidases
- Delays carbohydrate absorption
- Reduces postprandial glucose peaks

Benefits

- Effective control of postprandial glucose
- Weight-neutral or weight-loss potential
- Convenient dosing before meals
- Can be used in combination with other antidiabetic agents

VOGDEK GM 2 FORTE (Voglibose 0.3 mg + Glimepiride 2 mg + Metformin 1000 mg):

Product Information


- Brand Name: VOGDEK GM 2 FORTE
- Active Ingredients:
    - Voglibose 0.3 mg
    - Glimepiride 2 mg
    - Metformin 1000 mg
- Form: Tablets


Therapeutic Class

- Antidiabetic agent (combination)
- Alpha-glucosidase inhibitor + Sulfonylurea + Biguanide

Indications

- Treatment of type 2 diabetes mellitus
- Improves glycemic control
- Adjunct to diet and exercise


Mechanism of Action

- Voglibose:
    - Inhibits alpha-glucosidases
    - Delays carbohydrate absorption
    - Reduces postprandial glucose levels
- Glimepiride:
    - Stimulates insulin release from pancreatic beta cells
    - Lowers blood glucose levels
- Metformin:
    - Decreases glucose production in liver
    - Increases insulin sensitivity

Benefits

- Effective glycemic control
- Convenient combination therapy
- Reduced risk of complications associated with diabetes

Side Effects

- Common:
    - Hypoglycemia (low blood sugar)
    - Gastrointestinal upset (nausea, diarrhea)
    - Flatulence
    - Abdominal pain
- Less common:
    - Liver enzyme elevation
    - Anemia
    - Allergic reactions

Contraindications

- Hypersensitivity to voglibose, glimepiride, or metformin
- Type 1 diabetes
- Diabetic ketoacidosis
- Severe kidney or liver impairment
- Pregnancy and lactation (caution advised)

Precautions

- Monitor blood sugar, kidney function, and liver enzymes regularly
- Inform doctor about concomitant medications
- Caution in patients with:
    - Renal or hepatic impairment
    - History of heart failure

Storage

- Store at 20°C-25°C (68°F-77°F)
- Protect from light and moisture


Additional Information

- Monitor for signs of hypoglycemia and hyperglycemia
- Take with meals to minimize gastrointestinal upset
- Regular follow-up with doctor to adjust dosage or monitor side effects

Composition: Voglibose Mouth Dissolving Tablets 0.3 mg Brand Name: VOGDEK 0.3 MDPacking: BoxPacking Size: 10x10 Tablets

Composition: Voglibose IP 0.3 mg + Repaglinide IP 1 mgBrand Name: VOGDEK R 0.3/1Packing: 10x10 Tablets

Imeglimin Hydrochloride Tablets 500 mg / Igmlin-500

Uses
Management of type 2 diabetes mellitus: Used to help control blood sugar levels in adults with type 2 diabetes, usually alongside diet and exercise. It can be used alone or in combination with other antidiabetic medications.

Helps in reducing the risk of complications from diabetes, including kidney damage, vision loss, and cardiovascular events.

Details
Generic Name: Imeglimin Hydrochloride 500 mg

Brand Name: Igmlin-500

Class: Glimin class of oral antidiabetic agents (novel, dual-action)

Dosage: Usually taken as 500 mg twice daily with meals, or as directed by your doctor.

Mechanism of Action:

Enhances glucose-dependent insulin secretion from pancreatic beta cells.

Improves insulin sensitivity in muscle and liver tissues.

Reduces hepatic glucose production and preserves pancreatic beta-cell function.

Benefits
Dual mechanism: Addresses both insulin secretion and resistance, making it effective for comprehensive glycemic control.

May reduce long-term diabetes complications by helping maintain stable blood sugar levels.

Suitable as monotherapy or add-on therapy in patients inadequately controlled with other agents.

Generally fewer side effects compared to older antidiabetic drugs; most common include mild GI disturbances like nausea or abdominal discomfort.

Gliclazide 80 mg & Metformin 500 mg Tablets. Brand name is GLIQUICK-M 80. Packing 10x15 Tablets.

This is an oral antidiabetic combination medication used to manage type 2 diabetes mellitus, especially in adults whose blood sugar levels are not adequately controlled by diet, exercise, or monotherapy with either drug.

Linagliptin 5 mg Tablets. Brand Name is Linaplizin 5.  Linagliptin is a medicine used to treat type 2 diabetes. Type 2 diabetes is a condition where the body does not make enough insulin, or the insulin that it makes does not work properly.

Linagliptin and Metformin Hydrochloride Tablets. Brand name is Linaplizin Duo 2.5/1000. It works by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body's sensitivity to insulin. 

Linagliptin and Metformin Hydrochloride Tablets. Brand name is Linaplizin Duo 2.5/500.  It works by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body's sensitivity to insulin. 

Teneligliptin is used as a monotherapy, in addition to diet and exercise, to reduce high blood sugar levels in patients with type 2 diabetes mellitus.

Composition: Teneligliptin Tablets IP 20 mg. Brand name is "TENEQUICK 20"

Gliclazide Metformin Tablet is a combination oral medication used to manage type 2 diabetes mellitus in adults.